The Andrew McDonough B+ Foundation Childhood Cancer Research Grants 2026 support basic, translational, and clinical research aimed at improving treatments and advancing cures for childhood cancers. The program funds innovative projects that are directly related to pediatric cancer and have the potential to make a meaningful impact on the field.
For the 2026 cycle, the Foundation expects to award five to ten grants, with each selected project receiving $75,000 per year for two years, for a total of $150,000. Applications are open to eligible investigators with an MD, DO, PhD, or PharmD degree and must be submitted through ProposalCentral by September 3, 2026.
Eligibility Criteria
- Hold an MD, DO, PhD, or PharmD degree.
- Be an investigator at the Assistant Professor, Associate Professor, or Professor level.
- Instructors may also apply if they have a minimum two-year commitment from an accredited academic institution.
- The proposed research must be directly related to pediatric cancer.
- Projects may involve basic, translational, or clinical research provided that the work has relevance to childhood cancer and the potential to contribute to better treatments or cures.
- The Foundation does not restrict the program to one specific pediatric cancer type. Instead, applications are evaluated on the strength and relevance of the proposed science.
Funding Details
- Award amount: $75,000 per year
- Total funding: $150,000 per grant
- Funding period: 2 years
- Number of grants expected: 5–10
Deadline
- Application deadline: September 3, 2026
- Applications must be submitted through the ProposalCentral online grant application system.
Further Information
- The application includes several scientific, administrative, and institutional components.
- Official program page: View the official website
- Application portal: Apply through ProposalCentral
- Download the official program document: Download the PDF